Top Device Companies

C.R. Bard, Covidien Class-Action Suits Could Be Merged In West Virginia

C.R. Bard and Covidien are the targets in a pair of class-action suits whose lawyers want them merged into an even larger suit. The suits, 19 in Georgia, involve synthetic surgical mesh tissue supports made by the two companies. The Georgia lawyer has sought court permission to merge the suits with a similar West Virginia suit that involves 34 cases. At issue are the Avaulta Plus and Avaulta Solo products marketed by Bard and produced by Covidien. (Click here for more)

“Georgia Lawyers Want 19 Medical Mesh Suits Transferred To West Virginia” – West Virginia Record (7/19/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

C.R. Bard Says It Completes $200 Million Buy Of SenoRx

C.R. Bard said it has completed its $200 million acquisition of SenoRx, a specialist in devices for detecting and treating breast cancer. SenoRx products include its EnCor breast biopsy system, Gel Mark breast-tissue marker and Contura balloon catheter. C.R. Bard announced its intention to buy the company in May to make it part of its peripheral vascular unit. (Click here for more)

“C.R. Bard Closes $200 Million Acquisition Of SenoRx” – Bloomberg (AP) (7/6/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

C.R. Bard, Surgeon Sued After Implant Of Hip Device Went Wrong

C.R. Bard was named along with a surgeon in a lawsuit filed by a West Virginia couple over one of the company’s hip implants. The suit alledges the Avaulta Plus Anterior and Posterior BioSynthetic Support System was defective when it was implanted into the wife of the couple. The suit also alledges C.R. Bard and the surgeon were negligent for failing to take reasonable care in the making and implanting of the device. The couple seeks unstated compensatory and punitive damages for her pain and suffering and loss of a body organ. (Click here for more)

“Couple Sues C.R. Bard, Surgeon For Medical Malpractice, Negligence” – West Virginia Record (7/6/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

C.R. Bard, Bard Devices Sued Over Allegedly Defective Hernia Patch

C.R. Bard, one of its units, and a third company are being sued in West Virginia by a woman implanted with the Bard Composix Kugel Mesh Hernia Patch. The suit alleges the patch, which is implanted into the abdomen, was defective and that it was recalled six months later. The patient said she was not made aware of the device’s problems, that it later injured her and had to be removed. She seeks compensatory and punitive damages from Bard, Bard Devices and Davol. (Click here for more)

“Clarksburg Woman Sues C.R. Bard, Others For Defective Medical Device” – West Virginia Record (6/9/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

C.R. Bard Offers Friendly Buyout Of SenoRx For $200 Million

C.R. Bard says it plans to buy SenoRx, maker of cancer diagnostics, for about $200 million, with the target company’s approval. Regulators and shareholders still must approve the acquisition, but Bard expects the deal to be completed sometime during the third quarter. SenoRx makes the Encor breast biopsy system, Gel Mark breast tissue markers and Contura balloon catheter, driving $55.6 million in sales last year. Bard plans to make SenoRx part of its vascular unit. (Click here for more)

“C.R. Bard To Buy Breast Cancer Device Maker SenoRx” – BusinessWeek (AP) (5/5/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

C.R. Bard Offers Friendly Buyout Of SenoRx For $200 Million

C.R. Bard says it plans to buy SenoRx, maker of cancer diagnostics, for about $200 million, with the target company’s approval. Regulators and shareholders still must approve the acquisition, but Bard expects the deal to be completed sometime during the third quarter. SenoRx makes the Encor breast biopsy system, Gel Mark breast tissue markers and Contura balloon catheter, driving $55.6 million in sales last year. Bard plans to make SenoRx part of its vascular unit. (Click here for more)

“C.R. Bard To Buy Breast Cancer Device Maker SenoRx” – BusinessWeek (AP) (5/5/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

C.R. Bard Unit Freed Of Responsibility For Hernia Patch Injuring Patent

C.R. Bard’s Davol division was cleared by a the U.S. District Court in Rhode Island, freeing the unit of responsibility for injuries its hernia-repair patch caused. The decision ended the first of what are expected to be thousands of lawsuits over Davol’s Composix Kugel Mesh patch. The jury found the patch was negligently designed, but did not hold the patch to blame for injuring the Missouri man who brought the suit. A Bard spokesman said the trial was an important one because the decision was based on medical and scientific evidence. (Click here for more)

“Davol Prevails In First Hernia Patch Suit” – Providence Journal (4/18/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

Boston Sci Considers Selling Two Units To Offset Guidant Costs

Boston Scientific plans to sell two of its business specialties in an attempt to raise as much as $2.4 billion to deal with problems involving its Guidant subsidiary. The two business areas the company is considering are its pain-management business and its devices for neurovascular intervention. The pain-management products for neuromodulation are considered the more valuable of the set of products that could be put on the market. Likely buyers are Abbott Laboratories or Johnson & Johnson, with Medtronic, St. Jude, C.R. Bard andCovidien likely for the vascular treatment business. (Click here for more)

“Boston Scientific Unit Sale Seen As Long-Term Tradeoff” – Reuters (4/9/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

C.R. Bard, Covidien Accused Of Negligence In W. Va. Suit

C.R. Bard and Covidien are named in a suit brought by a West Virginia woman who accused them of negligence in making their implanted products. The suit said the devices implanted for pelvic organ prolapsed were not safe for use as intended and had design defects. The suit filed in a West Virginia court seeks compensatory and punitive damages. The medical center where the surgery occurred also was named in the suit. (Click here for more)

“Woman Sues Two Medical Companies For Negligence” – West Virginia Record (1/4/10)

Hot Off the Presses: Medical Device Market 2009: Interventional Cardiology - This 86-page Special Report from IN VIVO identifies the most important trends in cardiology devices in recent years, teases out the critical decisions that drove those developments, and takes you behind the scenes and into the minds of the architects of these new technologies and business strategies. Find out more...

C.R. Bard, Spire Agree For Fourth Time To Postpone Acquisition

C.R. Bard has agreed with Spire on further delay of Bard’s $15 million purchase of the hemodialysis catheter maker. The two moved their deadline back to Dec. 11, giving Bard more time to decide whether to close the deal. Bard and Spire agreed on the acquisition in September, but deadlines to close the deal have now been postponed four times. Spire is selling its catheter business to concentrate on its core solar-energy business. (Click here for more)

“Spire, Bard Postpone Merger Again” – Mass Device (12/7/09)

JUST PUBLISHED: Medical Device Market 2009: Interventional Cardiology - Find out who’s going beyond catheters and drug-eluting stents in this vibrant space with this 86-page Special Report previously published in IN VIVO: The Business & Medicine Report. Order yours now!